SEC Form 4 · accession 0000885590-15-000001
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ari Kellen
Officer — EVP, Company Group Chairman
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1,F2,F3 | — | Dec 30, 2014 | D | 75,000 | D | — | — | Common Shares, no par value | 0 | 0 | D |
| Restricted Share UnitsF1,F2,F4,F5 | — | Dec 30, 2014 | A | 75,000 | A | — | — | Common Shares, no par value | 225,000 | 75,000 | D |
Explanation of responses
- F1Each Restricted Share Unit represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (3).
- F2Amendment to the original Restricted Share Units ("RSUs") due to change in measurement dates as approved by the Talent and Compensation Committee of the Board of Directors.
- F3The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $107.96 on each of three measurement dates: 25% would vest on October 9, 2018, 50% on January 9, 2019 and 25% on April 9, 2019, with early vesting possible at higher TSR levels.
- F4The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $107.96 on each of three measurement dates: 25% would vest on October 9, 2016, 50% on January 9, 2017 and 25% on April 9, 2017, with early vesting possible at higher TSR levels.
- F5Represents the maximum number of Common Shares that may be issued under the RSU award. See note (4).